Sfoglia per Rivista
Imatinib mesylate in the treatment of newly diagnosed or refractory/resistant c-KIT positive acute myeloid leukemia.Results of an Italian Multicentric Phase II Study.
2007-01-01 Piccaluga PP; Malagola M; Rondoni M; Arpinati M; Paolini S; Candoni A; Fanin R; Messa E; Pirrotta MT; Lauria F; Visani G; Alberti D; Rancati F; Vinaccia V; Russo D; Saglio G; Baccarani M; Martinelli G.
IMMUNE RECONSTITUTION AND THYMIC FUNCTION AFTER REDUCED INTENSITY ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION.
2010-01-01 Bruno B; Omedè P; Cena S;Noviello M;Gilestro M;Cimolin L; Mattia S; Sfiligoi C; Galletto E; Veneziano L; Giaccone L; Sorasio R; Festuccia M; Fernando F; Brunello L; Massaia M; Aiuti A; Bonini C; Passera R; Boccadoro M
IMMUNE RECONSTITUTION OF THE T CELL COMPARTMENT BY FLOW CYTOMETRY FOLLOWING ALLOGENEIC NON MYELOABLATIVE HEMATOPOIETIC CELL TRANSPLANTATION IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES
2006-01-01 Gilestro M; Omedè P; Bruno B; Spagnolo M; Ferro F; Ruggeri M; Brunetti M; Caltagirone S; Di Bello C; Cimolin L; Sfiligoi C; Cena S; Giaccone L; Rotta M; Sorasio R; Boccadoro M
IMMUNE RECONSTITUTION OF THE T CELL COMPARTMENT IN HEMATOLOGICAL MALIGNANCIES FOLLOWING ALLOGENEIC NON MYELOABLATIVE HEMATOPOIETIC CELL TRANSPLANTATION
2007-01-01 P. Omedé; B. Bruno; M. Gilestro; M. Spagnolo; F. Ferro; M. Ruggeri; M. Brunetti; S. Caltagirone; C. Di Bello; A. Fantauzzo; L. Cimolin; C. Sfiligoi; S. Cena; L. Giaccone; F. Fiore; M. Rotta; R. Sorasio; M. Boccadoro
IMMUNE RECONSTITUTION OF THE T CELL COMPARTMENT IN MULTIPLE MYELOMA PATIENTS FOLLOWING ALLOGENEIC NON MYELOABLATIVE HEMATOPOIETIC CELL TRANSPLANTATION
2007-01-01 Omedè P; Bruno B; Gilestro M; Spagnolo M; Ferro F; Ruggeri M; Brunetti M; Caltagirone S; Di Bello C; Fantauzzo A; Cimolin L; Sfiligoi C; Cena S; Giaccone L; Fiore F; Rotta M; Sorasio R; Boccadoro M
IMMUNE RECONSTITUTION OF THE T CELL COMPARTMENT IN MULTIPLE MYELOMA PATIENTS FOLLOWING ALLOGENEIC NON MYELOABLATIVE HEMATOPOIETIC CELL TRANSPLANTATION
2007-01-01 P. Omede; B. Bruno; M. Gilestro; M. Spagnolo; F. Ferro; M. Ruggeri; M. Brunetti; S. Caltagirone; C. Di Bello; A. Fantauzzo; L. Cimolin; C. Sfiligoi; S. Cena; L. Giaccone; F. Fiore; M. Rotta; R. Sorasio; M. Boccadoro
IMMUNE SUPPRESSION OF BONE MARROW Vγ9Vδ2 T CELLS BY BONE MARROW STROMAL CELLS (BMSC) IN MULTIPLE MYELOMA
2022-01-01 C Giannotta, B Castella, E Tripoli, C Riganti, IC Salaroglio, M D'Agostino, M Massaia.
Immune-complexes and antiplatelet antibodies in idiopathic thrombocytopenic purpura.
1983-01-01 CAMPANA D ;BERGUI L ;CAMUSSI G ;MINIERO R ;MORGANDO MP ;SARDI A ;NOVARINO A ;CALIGARIS CAPPIO F
Immunoglobulin Heavy Chain Variable Genes and Alleles: New Entities, New Names and Implications for Research and Prognostication in CLL
2014-01-01 Xochelli, A; Agathangelidis, A; Kavakiotis, I; Minga, E; Sutton, LA; Baliakas, P; Chouvarda, I; Giudicelli, V; Vlahavas, I; Maglaveras, N; Bonello, L; Trentin, L; Montillo, M; Panagiotidis, P; Geisler, C; Langerak, AW; Pospisilova, S; Jelinek, DF; Oscier, D; Chiorazzi, N; Darzentas, N; Davi, F; Ghia, P; Rosenquist, R; Hadzidimitriou, A; Belessi, C; Lefranc, MP; Stamatopoulos, K
Immunoglobulin variable heavy-chain (Ig Vh) mutational status and tumor microenvironment interactions in B-cell chronic lymphocytic leukaemia
2007-01-01 Pantaleoni F; Coscia M; Bussolati B; Deambrosis I; Peola S; Rigoni M; Boccadoro M; Camussi G; Massaia M
Immunophenotypic profile and cytogenetic aberrations detected by interphase FISH in B-CLL patients
2011-01-01 Ruggeri M; Caltagirone S; Gilestro M; Aschero S; Astolfi M; Oddolo D; Saraci E; Muccio VE; Bergui L; Coscia M; Omedè P; Boccadoro M
IMMUNOPHENOTYPIC RESPONSE AFTER ALLOGRAFTING IN MULTIPLE MYELOMA
2013-01-01 Luisa Giaccone; Lucia Brunello; Roberto Passera; Moreno Festuccia; Milena Gilestro; Enrico Maffini; Federica Ferrando; Mario Boccadoro; Paola Omede’; Benedetto Bruno.
IMMUNOPHENOTYPIC RESPONSE AFTER ALLOGRAFTING IN MULTIPLE MYELOMA
2013-01-01 Luisa Giaccone; Lucia Brunello; Roberto Passera; Moreno Festuccia; Milena Gilestro; Enrico Maffini; Federica Ferrando; Federica Testa; Mario Boccadoro; Paola Omede’; Benedetto Bruno.
Immunophenotypic, cytogenetic and molecular investigations in two cases of CALLA positive acute myeloid leukemia
1990-01-01 Fagioli, F; Lanza, F; Carli, M G; Cuneo, A; Gandini, D; Del Senno, L; Castoldi, G
Impact of ABO incompatibility on patients’ outcome after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia-a report from the acute leukemia working party of the EBMT
2017-01-01 Canaani, Jonathan; Savani, Bipin N.; Labopin, Myriam; Huang, Xiao-Jun; Ciceri, Fabio; Arcese, William; Tischer, Johanna; Koc, Yener; Bruno, Benedetto; Gulbas, Zafer; Blaise, Didier; Maertens, Johan; Ehninger, Gerhard; Mohty, Mohamad; Nagler, Arnon
Impact of age on the outcome of patients with chronic myeloid leukemia in late chronic phase: results of a phase II study of the GIMEMA CML Working Party
2007-01-01 ROSTI G; IACOBUCCI I; BASSI S; CASTAGNETTI F; AMABILE M; CILLONI D; POERIO A; SOVERINI S; PALANDRI F; REGE CAMBRIN G; IULIANO F; ALIMENA G; LATAGLIATA R; TESTONI N; PANE F; SAGLIO G; BACCARANI M; MARTINELLI G
IMPACT OF BCR-ABL MUTATIONS ON RESPONSE TO DASATINIB IN ELDERLY CHRONIC MYELOID LEUKEMIA PATIENTS RESISTANT TO IMATINIB
2010-01-01 Tiribelli M; Latagliata R; Breccia M; Luciano L; Castagnetti F; Gozzini A ; Rege Cambrin G; Annunziata M; Stagno F; Pregno P; Albano F; Abruzzese E; Musto P; Sorà F; Ferrero D; Montefusco E; Cavazzini F; Binotto G; Fanin R; Pane F; Rosti G; Santini V; Fava C; Alimena G; Vigneri P
IMPACT OF BCR-ABL1 TRANSCRIPT TYPE IN CHRONIC MYELOID LEUKEMIA TREATED FRONTLINE WITH NILOTINIB
2017-01-01 Castagnetti, F; Gugliotta, G; Breccia, M; Stagno, F; D'Adda, M; Levato, L; Angelucci, E; Martino, B; Tiribelli, M; Fava, C; Binotto, G; Capodanno, I; Bocchia, M; Bergamaschi, M; Russo-Rossi, A; Cavazzini, F; Abruzzese, E; Soverini, S; Foa, R; Cavo, M; Martinelli, G; Saglio, G; Pane, F; Baccarani, M; Rosti, G
Impact of maintenance therapy on subsequent treatment in patients with newly diagnosed multiple myeloma: Use of “progression-free survival 2” as a clinical trial end-point
2015-01-01 Dimopoulos, Meletios A; Petrucci, Maria T.; Foà, Robin; Catalano, John; Kropff, Martin; Terpos, Evangelos; Zhang, Jingshan; Grote, Lara; Jacques, Christian; Palumbo, Antonio
IMPACT OF THE MEVALONATE PATHWAY AND HIF/PGP AXIS IN MODULATING MULTIDRUG-RESISTANCE IN UNMUTATED CLL CELLS
2011-01-01 Marta Coscia; Micol Rigoni; Chiara Riganti; Ivana Campia; Candida Vitale; Silvia Peola; Barbara Castella; Valentina Griggio; Francesca Pantaleoni; Patrizia Sciancalepore; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Imatinib mesylate in the treatment of newly diagnosed or refractory/resistant c-KIT positive acute myeloid leukemia.Results of an Italian Multicentric Phase II Study. | 2007 | Piccaluga PP; Malagola M; Rondoni M; Arpinati M; Paolini S; Candoni A; Fanin R; Messa E; Pirrotta MT; Lauria F; Visani G; Alberti D; Rancati F; Vinaccia V; Russo D; Saglio G; Baccarani M; Martinelli G. | |
| IMMUNE RECONSTITUTION AND THYMIC FUNCTION AFTER REDUCED INTENSITY ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION. | 2010 | Bruno B; Omedè P; Cena S;Noviello M;Gilestro M;Cimolin L; Mattia S; Sfiligoi C; Galletto E; Veneziano L; Giaccone L; Sorasio R; Festuccia M; Fernando F; Brunello L; Massaia M; Aiuti A; Bonini C; Passera R; Boccadoro M | |
| IMMUNE RECONSTITUTION OF THE T CELL COMPARTMENT BY FLOW CYTOMETRY FOLLOWING ALLOGENEIC NON MYELOABLATIVE HEMATOPOIETIC CELL TRANSPLANTATION IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES | 2006 | Gilestro M; Omedè P; Bruno B; Spagnolo M; Ferro F; Ruggeri M; Brunetti M; Caltagirone S; Di Bello C; Cimolin L; Sfiligoi C; Cena S; Giaccone L; Rotta M; Sorasio R; Boccadoro M | |
| IMMUNE RECONSTITUTION OF THE T CELL COMPARTMENT IN HEMATOLOGICAL MALIGNANCIES FOLLOWING ALLOGENEIC NON MYELOABLATIVE HEMATOPOIETIC CELL TRANSPLANTATION | 2007 | P. Omedé; B. Bruno; M. Gilestro; M. Spagnolo; F. Ferro; M. Ruggeri; M. Brunetti; S. Caltagirone; C. Di Bello; A. Fantauzzo; L. Cimolin; C. Sfiligoi; S. Cena; L. Giaccone; F. Fiore; M. Rotta; R. Sorasio; M. Boccadoro | |
| IMMUNE RECONSTITUTION OF THE T CELL COMPARTMENT IN MULTIPLE MYELOMA PATIENTS FOLLOWING ALLOGENEIC NON MYELOABLATIVE HEMATOPOIETIC CELL TRANSPLANTATION | 2007 | Omedè P; Bruno B; Gilestro M; Spagnolo M; Ferro F; Ruggeri M; Brunetti M; Caltagirone S; Di Bello C; Fantauzzo A; Cimolin L; Sfiligoi C; Cena S; Giaccone L; Fiore F; Rotta M; Sorasio R; Boccadoro M | |
| IMMUNE RECONSTITUTION OF THE T CELL COMPARTMENT IN MULTIPLE MYELOMA PATIENTS FOLLOWING ALLOGENEIC NON MYELOABLATIVE HEMATOPOIETIC CELL TRANSPLANTATION | 2007 | P. Omede; B. Bruno; M. Gilestro; M. Spagnolo; F. Ferro; M. Ruggeri; M. Brunetti; S. Caltagirone; C. Di Bello; A. Fantauzzo; L. Cimolin; C. Sfiligoi; S. Cena; L. Giaccone; F. Fiore; M. Rotta; R. Sorasio; M. Boccadoro | |
| IMMUNE SUPPRESSION OF BONE MARROW Vγ9Vδ2 T CELLS BY BONE MARROW STROMAL CELLS (BMSC) IN MULTIPLE MYELOMA | 2022 | C Giannotta, B Castella, E Tripoli, C Riganti, IC Salaroglio, M D'Agostino, M Massaia. | |
| Immune-complexes and antiplatelet antibodies in idiopathic thrombocytopenic purpura. | 1983 | CAMPANA D ;BERGUI L ;CAMUSSI G ;MINIERO R ;MORGANDO MP ;SARDI A ;NOVARINO A ;CALIGARIS CAPPIO F | |
| Immunoglobulin Heavy Chain Variable Genes and Alleles: New Entities, New Names and Implications for Research and Prognostication in CLL | 2014 | Xochelli, A; Agathangelidis, A; Kavakiotis, I; Minga, E; Sutton, LA; Baliakas, P; Chouvarda, I; Giudicelli, V; Vlahavas, I; Maglaveras, N; Bonello, L; Trentin, L; Montillo, M; Panagiotidis, P; Geisler, C; Langerak, AW; Pospisilova, S; Jelinek, DF; Oscier, D; Chiorazzi, N; Darzentas, N; Davi, F; Ghia, P; Rosenquist, R; Hadzidimitriou, A; Belessi, C; Lefranc, MP; Stamatopoulos, K | |
| Immunoglobulin variable heavy-chain (Ig Vh) mutational status and tumor microenvironment interactions in B-cell chronic lymphocytic leukaemia | 2007 | Pantaleoni F; Coscia M; Bussolati B; Deambrosis I; Peola S; Rigoni M; Boccadoro M; Camussi G; Massaia M | |
| Immunophenotypic profile and cytogenetic aberrations detected by interphase FISH in B-CLL patients | 2011 | Ruggeri M; Caltagirone S; Gilestro M; Aschero S; Astolfi M; Oddolo D; Saraci E; Muccio VE; Bergui L; Coscia M; Omedè P; Boccadoro M | |
| IMMUNOPHENOTYPIC RESPONSE AFTER ALLOGRAFTING IN MULTIPLE MYELOMA | 2013 | Luisa Giaccone; Lucia Brunello; Roberto Passera; Moreno Festuccia; Milena Gilestro; Enrico Maffini; Federica Ferrando; Mario Boccadoro; Paola Omede’; Benedetto Bruno. | |
| IMMUNOPHENOTYPIC RESPONSE AFTER ALLOGRAFTING IN MULTIPLE MYELOMA | 2013 | Luisa Giaccone; Lucia Brunello; Roberto Passera; Moreno Festuccia; Milena Gilestro; Enrico Maffini; Federica Ferrando; Federica Testa; Mario Boccadoro; Paola Omede’; Benedetto Bruno. | |
| Immunophenotypic, cytogenetic and molecular investigations in two cases of CALLA positive acute myeloid leukemia | 1990 | Fagioli, F; Lanza, F; Carli, M G; Cuneo, A; Gandini, D; Del Senno, L; Castoldi, G | |
| Impact of ABO incompatibility on patients’ outcome after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia-a report from the acute leukemia working party of the EBMT | 2017 | Canaani, Jonathan; Savani, Bipin N.; Labopin, Myriam; Huang, Xiao-Jun; Ciceri, Fabio; Arcese, William; Tischer, Johanna; Koc, Yener; Bruno, Benedetto; Gulbas, Zafer; Blaise, Didier; Maertens, Johan; Ehninger, Gerhard; Mohty, Mohamad; Nagler, Arnon | |
| Impact of age on the outcome of patients with chronic myeloid leukemia in late chronic phase: results of a phase II study of the GIMEMA CML Working Party | 2007 | ROSTI G; IACOBUCCI I; BASSI S; CASTAGNETTI F; AMABILE M; CILLONI D; POERIO A; SOVERINI S; PALANDRI F; REGE CAMBRIN G; IULIANO F; ALIMENA G; LATAGLIATA R; TESTONI N; PANE F; SAGLIO G; BACCARANI M; MARTINELLI G | |
| IMPACT OF BCR-ABL MUTATIONS ON RESPONSE TO DASATINIB IN ELDERLY CHRONIC MYELOID LEUKEMIA PATIENTS RESISTANT TO IMATINIB | 2010 | Tiribelli M; Latagliata R; Breccia M; Luciano L; Castagnetti F; Gozzini A ; Rege Cambrin G; Annunziata M; Stagno F; Pregno P; Albano F; Abruzzese E; Musto P; Sorà F; Ferrero D; Montefusco E; Cavazzini F; Binotto G; Fanin R; Pane F; Rosti G; Santini V; Fava C; Alimena G; Vigneri P | |
| IMPACT OF BCR-ABL1 TRANSCRIPT TYPE IN CHRONIC MYELOID LEUKEMIA TREATED FRONTLINE WITH NILOTINIB | 2017 | Castagnetti, F; Gugliotta, G; Breccia, M; Stagno, F; D'Adda, M; Levato, L; Angelucci, E; Martino, B; Tiribelli, M; Fava, C; Binotto, G; Capodanno, I; Bocchia, M; Bergamaschi, M; Russo-Rossi, A; Cavazzini, F; Abruzzese, E; Soverini, S; Foa, R; Cavo, M; Martinelli, G; Saglio, G; Pane, F; Baccarani, M; Rosti, G | |
| Impact of maintenance therapy on subsequent treatment in patients with newly diagnosed multiple myeloma: Use of “progression-free survival 2” as a clinical trial end-point | 2015 | Dimopoulos, Meletios A; Petrucci, Maria T.; Foà, Robin; Catalano, John; Kropff, Martin; Terpos, Evangelos; Zhang, Jingshan; Grote, Lara; Jacques, Christian; Palumbo, Antonio | |
| IMPACT OF THE MEVALONATE PATHWAY AND HIF/PGP AXIS IN MODULATING MULTIDRUG-RESISTANCE IN UNMUTATED CLL CELLS | 2011 | Marta Coscia; Micol Rigoni; Chiara Riganti; Ivana Campia; Candida Vitale; Silvia Peola; Barbara Castella; Valentina Griggio; Francesca Pantaleoni; Patrizia Sciancalepore; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile